Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
64.10
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
306
Open
64.10
Bid (Size)
63.44 (300)
Ask (Size)
64.06 (300)
Prev. Close
64.10
Today's Range
64.10 - 64.10
52wk Range
42.52 - 68.64
Shares Outstanding
2,222,113,553
Dividend Yield
3.93%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Healthcare Stocks That Fall Short
September 14, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme...
Via
StockStory
Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?
↗
September 13, 2026
As management tackles key issues head-on, Bristol Myers Squibb stock offers a steady 4% yield, with further upside potential.
Via
The Motley Fool
Topics
Intellectual Property
Performance
YTD
+19.9%
+19.9%
1 Month
-0.8%
-0.8%
3 Month
+14.0%
+14.0%
6 Month
+7.4%
+7.4%
1 Year
+38.3%
+38.3%
More News
Read More
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
September 10, 2026
Via
Investor Brand Network
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
September 10, 2026
Via
Investor Brand Network
Bristol-Myers Squibb (NYSE:BMY) Passes the Dividend Screen, but Payout Sustainability Is the Key Question
↗
September 10, 2026
Via
Chartmill
Bristol-Myers Squibb (NYSE:BMY) Flashes Strong Technical Breakout Setup
↗
September 05, 2026
Via
Chartmill
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
September 10, 2026
Via
Investor Brand Network
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
September 10, 2026
From
BioMedWire
Via
GlobeNewswire
Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-Directed CAR T Cell Therapy, Arlocabtagene Autoleucel ...
September 08, 2026
From
Bristol Myers Squibb
Via
Business Wire
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?
↗
September 03, 2026
Via
The Motley Fool
Is BioNTech Stock a No-Brainer Buy on the Dip?
↗
September 02, 2026
Via
The Motley Fool
2 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now
↗
September 02, 2026
Via
The Motley Fool
Branded Pharmaceuticals Stocks Q2 Teardown: Bristol-Myers Squibb (NYSE:BMY) Vs The Rest
August 31, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
3 Reasons to Sell BMY and 1 Stock to Buy Instead
August 31, 2026
Via
StockStory
Topics
Stocks
Bristol Myers Squibb Presents Data Up to Five Years Reinforcing the Long-Term Efficacy and Safety of Camzyos (mavacamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) at the European Society of Cardiology (ESC) Congress 2026
August 29, 2026
From
Bristol Myers Squibb
Via
Business Wire
Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors
↗
August 29, 2026
Via
The Motley Fool
Topics
Intellectual Property
1 S&P 500 Stock with Promising Prospects and 2 Facing Challenges
August 28, 2026
Via
StockStory
Topics
Stocks
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
August 26, 2026
Via
FinancialNewsMedia
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
August 26, 2026
From
MarketNewsUpdates.com
Via
GlobeNewswire
3 Dividend Stocks to Hold for the Next 10 Years
↗
August 25, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset?
↗
August 21, 2026
Via
The Motley Fool
Topics
ETFs
Pharmaceuticals Stocks Q2 Highlights: Ocular Therapeutix (NASDAQ:OCUL)
August 20, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Corcept (NASDAQ:CORT)
August 19, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
↗
August 18, 2026
Via
The Motley Fool
1 Momentum Stock on Our Buy List and 2 We Turn Down
August 17, 2026
Via
StockStory
Frequently Asked Questions
Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 64.10
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 09/14/26 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 142.44B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 142B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
